Ajim Tamboli

Ajim Tamboli

Geen lopende functies
49 jaar
Finance
Health Technology
Consumer Services

Profiel

Ajim Akbar Tamboli is currently Chief Financial Officer at First Tracks Biotherapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at Monte Rosa Therapeutics, Inc. from 2020 to 2023, at Rodin Therapeutics, Inc. from 2019 to 2020, and at ADARx Pharmaceuticals, Inc. Held the position of Analyst at Asymmetry Capital Management LP from 2018 to 2019 and at Columbia Management Investment Advisers LLC from 2010 to 2013.
Worked as Senior Portfolio Manager at Hovan Capital Management LLC from 2008 to 2009.
Was Research Analyst at Lehman Brothers, Inc. from 2003 to 2007 and Consultant at Duquesne Capital Management LLC in 2002.
Served as Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2000 to 2001.
Also held the role of Partner & Analyst at Endurant Capital Management LP.
Education includes undergraduate degree in 1998 and graduate degree in 2002 from the University of Pennsylvania.

Actieve functies van Ajim Tamboli

BedrijvenFunctieBegin

Eerdere bekende functies van Ajim Tamboli

BedrijvenFunctieEinde
MONTE ROSA THERAPEUTICS, INC. Financieel Directeur/CFO 08-08-2023
Financieel Directeur/CFO 01-01-2020
Analyst-Equity 01-01-2019
Analyst-Equity 01-07-2013
Analyst-Equity 01-12-2009
Ervaring van Ajim Tamboli in detail bekijken

Opleiding van Ajim Tamboli

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

96

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Finance

Finance

Finance

Finance

Consumer Services

Finance

Health Technology

Finance

Finance

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Ajim Tamboli